JAZZ (US) share price forecast & AI signal — Jazz Pharmaceuticals plc
Week of 2026-10-30 · Healthcare
Exact confidence, 1-week / 1-month / 3-month breakdown, plain-English AI write-up, bull-vs-bear debate, support & resistance.
Get 5 free tokens — no card Already a member? Open the full analysisWhat the model sees in JAZZ
Jazz Pharmaceuticals plc is a Healthcare stock listed on the US. For the week of 2026-10-30 the ACE machine-learning model rates it a HOLD with low confidence, based on technical indicators and the stock's own historical patterns across three time horizons. The direction is updated every model run.
About Jazz Pharmaceuticals plc
Jazz Pharmaceuticals plc identifies, develops, and commercializes pharmaceutical products in the United States, Europe, and internationally. The company offers Xywav to treat cataplexy or excessive daytime sleepiness (EDS) with narcolepsy and idiopathic hypersomnia (IH); Epidiolex for seizures associated with Lennox-Gastaut syndrome (LGS), Dravet syndrome (DS), or tuberous sclerosis complex (TSC); Rylaze for the treatment of acute lymphoblastic leukemia or lymphoblastic lymphoma; Enrylaze to treat acute lymphoblastic leukemia and lymphoblastic lymphoma; Zepzelca for the treatment of metastatic small cell lung cancer with disease progression on or after platinum-based chemotherapy;...
Recent closes
| Date | Close |
|---|---|
| 2026-11-06 | $234.76 |
| 2026-11-05 | $227.32 |
| 2026-11-04 | $234.66 |
| 2026-11-03 | $229.74 |
| 2026-11-02 | $214.44 |
| 2026-10-30 | $215.98 |
| 2026-10-29 | $207.83 |
JAZZ FAQ
Is Jazz Pharmaceuticals plc (JAZZ) a buy or sell this week?
The ACE Stock Bots machine-learning model rates JAZZ a HOLD for the week of 2026-10-30 with low confidence. The exact confidence and the 1-week, 1-month and 3-month breakdown are free with a signup (5 analysis tokens, no card).
What is the AI share price forecast for JAZZ?
Every week the model scores JAZZ across three horizons using technical indicators and the stock's own historical patterns. An AI then writes a plain-English summary with support and resistance levels, and a bull analyst and a bear analyst argue the case.
Is this financial advice?
No. ACE Stock Bots provides general information generated by software. It does not consider your objectives, financial situation or needs. Read the disclaimer and consider licensed advice before acting.
Other Healthcare stocks on the US
This week's top US picks · All US stocks
Signals are generated by software for general information only and are not a recommendation to buy or sell. See the disclaimer.